Predictive oncology issues letter to shareholders

Eagan, minn., march 09, 2023 (globe newswire) -- predictive oncology (nasdaq: poai), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities to accelerate oncologic drug discovery and enable drug development, today issued the following letter to shareholders:

POAI Ratings Summary

POAI Quant Ranking